
About Everyuth
Everyuth is a publicly listed company based in Mumbai (India) founded in 2013. It sells skincare items like scrubs, masks, and washes online for skin care needs. It operates on a B2C and D2C model. The company has 129 employees. Its Indian entity Zydus Wellness Limited reported revenue of βΉ3,967 Cr. Everyuth offers products and services including Scrub, Peel Off Mask, Face Wash, Tan Removal, and Body Lotion. Its focus areas include Personal Care, Skincare, Facial Products and Body Treatments. Its competitors include Mamaearth, WOW Skin Science and Juicy Chemistry; 3 of its 3 listed competitors have raised funding.
Company details
Everyuth Naturals is an online platform specializing in skincare products, including scrubs, peel-off masks, face washes, and lotions designed for benefits like exfoliation and hydration. It operates through an e-commerce site where users can browse categories and select products based on skin types. The company provides resources such as blogs on skincare routines and product guides, targeting consumers seeking effective, everyday skin solutions. Activities include product sales, educational content, and trend updates, though specific locations are not detailed.
- Headquarters Mumbai, India
- Employees 129
- Stage Public
- SectorsConsumer
- Website everyuth.com
- Social X Facebook Instagram YouTube
- Legal Name Zydus Wellness Limited
- Date of Incorporation 01 Nov, 1994
- Jurisdiction Ahmedabad, Gujarat, India
- Market Cap₹14,723 Cr
ZYDUSWELL · NSE
- Share Price₹483.30
+4.44% today
- Revenue₹3,961 Cr
FY 2025-26 · +46.2% YoY
- EBITDA₹469 Cr
Margin 11.8%
- Net Profit₹229 Cr
FY 2025-26 · -30.8% YoY
- P/E (TTM)66.5x
P/B 2.5x
- ROE4.0%
ROCE 4.9%
- Debt / Equity0.29
Interest cover 30.4x
- Employee Count129
Associated legal entities of Everyuth
Everyuth operates through Zydus Wellness Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zydus Wellness Limited Listed CIN L15201GJ1994PLC023490 | Active | 01 Nov 1994 | Ahmedabad, Gujarat | ₹3,967 Cr | 129 | 11 | View details |
Products & Services of Everyuth
Everyuth offers a comprehensive portfolio of products and services, including Scrub, Peel Off Mask, Face Wash, Tan Removal, and Body Lotion.
Product for removing dead skin cells and purifying skin.
Mask that deeply cleanses and fights skin impurities.
Wash for daily face cleaning and oil control.
Product to reduce tan and brighten skin tone.
Lotion for hydrating and nourishing body skin.
Gel for soothing and refreshing irritated skin.
Apps and channels of Everyuth
its YouTube channel Everyuth Naturals has 20.9K subscribers and 30 videos.
Videos from Everyuth
The most watched videos on Everyuth's YouTube channel, Everyuth Naturals (20.9K subscribers). Click a video to play it here.
More on Everyuth Naturals.
Board of directors of Zydus Wellness Limited (Everyuth)
Zydus Wellness Limited is the primary company behind Everyuth. The board of Zydus Wellness Limited currently have 8 directors; the longest-serving is Ganesh Narayan Nayak, appointed in 2006. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ganesh Narayan Nayak DIN 00017481 | Director | 27 Jul 2006 | 20 yrs 3 mo | Zydus Wellness Limited |
| Sharvil Pankajbhai Patel DIN 00131995 | Director | 27 Apr 2009 | 17 yrs 6 mo | Zydus Wellness Limited |
| Tarun Arora DIN 07185311 | Whole-time director | 14 May 2015 | 11 yrs 5 mo | Zydus Wellness Limited |
| Kulin Sanjay Lalbhai DIN 05206878 | Director | 18 Nov 2016 | 9 yrs 11 mo | Zydus Wellness Limited |
| Dharmishta Narendraprasad Raval DIN 02792246 | Director | 11 Mar 2019 | 7 yrs 7 mo | Zydus Wellness Limited |
| Srivishnu Raju Nandyala DIN 00025063 | Director | 11 Mar 2019 | 7 yrs 7 mo | Zydus Wellness Limited |
| Monappa Arun Akhil DIN 09784366 | Director | 17 May 2023 | 3 yrs 5 mo | Zydus Wellness Limited |
| Apurva Shishir Diwanji DIN 00032072 | Director | 18 May 2026 | 5 mo | Zydus Wellness Limited |
IPO & Listings of Everyuth
Everyuth is a publicly listed company on the NSE with ticker symbol ZYDUSWELL in India, operating in the FMCG sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: ZYDUSWELL
- Listed entityZydus Wellness Limited
- Exchange sectorFMCG
Financials of Everyuth
Exchange-reported figures of Zydus Wellness Limited, the listed company behind Everyuth (NSE: ZYDUSWELL).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 3,961 | 2,709 | 2,328 | 2,255 | 2,009 | 1,867 | 1,767 |
| Revenue growth | +46.2% | +16.4% | +3.2% | +12.2% | +7.6% | +5.7% | - |
| EBITDA | 469 | 380 | 290 | 327 | 345 | 212 | 277 |
| EBITDA margin | +11.8% | +14.0% | +12.5% | +14.5% | +17.2% | +11.4% | +15.7% |
| Profit before tax | 230 | 359 | 260 | 291 | 306 | 112 | 121 |
| Net profit | 229 | 331 | 279 | 319 | 309 | 251 | 181 |
| Net profit margin | +5.8% | +12.2% | +12.0% | +14.2% | +15.4% | +13.4% | +10.2% |
| EPS (βΉ) | 6.20 | 54.54 | 41.97 | 48.81 | 48.54 | 18.66 | 24.58 |
| Balance sheet | |||||||
| Total assets | 9,103 | 5,883 | 5,704 | 5,434 | 5,246 | 5,133 | 4,994 |
| Net worth | 5,826 | 5,672 | 5,358 | 5,123 | 4,844 | 4,568 | 3,461 |
| Total debt | 3,203 | 188 | 329 | 297 | 387 | 550 | 1,519 |
| Cash & bank | 111 | 73.90 | 240 | 38.10 | 170 | 253 | 82.42 |
| Net working capital | 790 | 510 | 694 | 439 | 340 | 313 | 69.41 |
| Cash flow | |||||||
| Cash from operations | 226 | 380 | 246 | 91.70 | 237 | 287 | 259 |
| Cash from investing | (2,881) | (207) | (178) | (84.90) | (58.93) | (10.41) | (17.12) |
| Cash from financing | 2,698 | (186) | (25.70) | (138) | (234) | (216) | (260) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,437 | 1,485 | 965 | 650 | 861 | 913 | 462 | 493 |
| Revenue growth (YoY) | +66.9% | +62.6% | +108.9% | +32.0% | +2.4% | - | - | - |
| Other income | 3.80 | 1.20 | 0.80 | 1.40 | 3.00 | 0.80 | 3.80 | 9.90 |
| EBITDA | 242 | 270 | 54.40 | (11.20) | 156 | 190 | 14.80 | 19.60 |
| EBITDA margin | +16.9% | +18.3% | +5.6% | -1.7% | +18.1% | +20.9% | +3.3% | +4.0% |
| Depreciation | 57.10 | 55.30 | 55.50 | 25.10 | 10.80 | 13.20 | 5.20 | 4.90 |
| Interest | 26.30 | 38.70 | 41.20 | 15.70 | 2.50 | 4.20 | 3.30 | 0.90 |
| Profit before tax | 162 | 177 | (41.50) | (50.60) | 145 | 173 | 10.10 | 23.70 |
| Tax | 43.20 | 15.30 | (1.60) | 2.20 | 17.40 | 1.50 | 3.70 | 2.80 |
| Net profit | 119 | 162 | (39.90) | (52.80) | 128 | 172 | 6.40 | 20.90 |
| EPS (βΉ) | 3.74 | 5.09 | (1.25) | (1.66) | 20.10 | 27.01 | 1.01 | 3.28 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 582 | 354 | 245 | 251 | 216 | 114 | 153 |
| Revenue growth | +64.3% | +44.7% | -2.6% | +16.2% | +90.0% | -25.8% | - |
| EBITDA | 72.90 | 41.90 | 33.00 | 38.30 | (5.32) | (177) | (21.18) |
| EBITDA margin | +12.5% | +11.8% | +13.5% | +15.3% | -2.5% | -155.3% | -13.8% |
| Profit before tax | 48.80 | 39.80 | 44.80 | 47.20 | 5.22 | (188) | (54.94) |
| Net profit | 45.92 | 28.20 | 33.10 | 66.20 | 12.70 | (55.81) | (40.44) |
| Net profit margin | +7.9% | +8.0% | +13.5% | +26.4% | +5.9% | -49.0% | -26.4% |
| EPS (βΉ) | 1.18 | 4.67 | 5.30 | 10.44 | 2.00 | (28.62) | (7.06) |
| Balance sheet | |||||||
| Total assets | 4,221 | 4,170 | 4,091 | 4,038 | 4,049 | 4,073 | 4,734 |
| Net worth | 4,033 | 4,034 | 4,036 | 4,034 | 4,000 | 4,019 | 3,215 |
| Total debt | 181 | 130 | 50.70 | 0.30 | 46.48 | 50.40 | 1,516 |
| Cash & bank | 7.50 | 11.00 | 9.60 | 15.40 | 57.35 | 84.00 | 29.80 |
| Net working capital | 58.20 | 22.20 | 102 | 115 | 68.50 | 88.60 | 19.05 |
| Cash flow | |||||||
| Cash from operations | 35.20 | 40.00 | 26.00 | 36.70 | (16.27) | (51.73) | (19.67) |
| Cash from investing | (32.00) | (88.40) | (47.10) | 0.70 | 39.33 | 816 | 267 |
| Cash from financing | (0.30) | 43.40 | 15.40 | (79.30) | (37.69) | (710) | (260) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 153 | 133 | 153 | 156 | 141 | 128 | 99.70 | 63.30 |
| Revenue growth (YoY) | +8.6% | +3.7% | +53.1% | +146.5% | +122.2% | - | - | - |
| Other income | 4.90 | 4.80 | 4.40 | 2.00 | 0.70 | 0.50 | 3.20 | 4.10 |
| Total expenses | 141 | 113 | 133 | 138 | 125 | 114 | 84.80 | 55.80 |
| EBITDA | 11.80 | 19.80 | 19.20 | 18.40 | 15.50 | 14.20 | 14.90 | 7.50 |
| EBITDA margin | +8.7% | +17.8% | +13.6% | +12.7% | +11.9% | +12.2% | +16.8% | +14.1% |
| Depreciation | 6.30 | 6.30 | 6.30 | 6.40 | 6.00 | 7.40 | 1.00 | 0.90 |
| Interest | 3.00 | 3.10 | 3.10 | 2.50 | 2.30 | 2.10 | 1.40 | 0.20 |
| Profit before tax | 7.40 | 15.20 | 14.20 | 11.50 | 7.90 | 5.20 | 15.70 | 10.50 |
| Tax | 1.90 | 1.90 | 2.10 | 3.90 | 3.30 | 1.50 | 3.90 | 2.50 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,437 | 1,485 | 965 | 650 | 861 | 913 | 462 | 493 |
| Revenue growth (YoY) | +66.9% | +62.6% | +108.9% | +32.0% | +2.4% | - | - | - |
| Other income | 3.80 | 1.20 | 0.80 | 1.40 | 3.00 | 0.80 | 3.80 | 9.90 |
| EBITDA | 242 | 270 | 54.40 | (11.20) | 156 | 190 | 14.80 | 19.60 |
| EBITDA margin | +16.9% | +18.3% | +5.6% | -1.7% | +18.1% | +20.9% | +3.3% | +4.0% |
| Depreciation | 57.10 | 55.30 | 55.50 | 25.10 | 10.80 | 13.20 | 5.20 | 4.90 |
| Interest | 26.30 | 38.70 | 41.20 | 15.70 | 2.50 | 4.20 | 3.30 | 0.90 |
| Profit before tax | 162 | 177 | (41.50) | (50.60) | 145 | 173 | 10.10 | 23.70 |
| Tax | 43.20 | 15.30 | (1.60) | 2.20 | 17.40 | 1.50 | 3.70 | 2.80 |
| Net profit | 119 | 162 | (39.90) | (52.80) | 128 | 172 | 6.40 | 20.90 |
| EPS (βΉ) | 3.74 | 5.09 | (1.25) | (1.66) | 20.10 | 27.01 | 1.01 | 3.28 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 3,961 | 2,709 | 2,328 | 2,255 | 2,009 | 1,867 | 1,767 |
| Revenue growth | +46.2% | +16.4% | +3.2% | +12.2% | +7.6% | +5.7% | - |
| Other income | 6.40 | 19.50 | 17.40 | 4.90 | 10.40 | 8.94 | 10.71 |
| Total expenses | 3,492 | 2,329 | 2,037 | 1,928 | 1,664 | 1,654 | 1,490 |
| Employee cost | 313 | 237 | 193 | 167 | 164 | 164 | 156 |
| EBITDA | 469 | 380 | 290 | 327 | 345 | 212 | 277 |
| EBITDA margin | +11.8% | +14.0% | +12.5% | +14.5% | +17.2% | +11.4% | +15.7% |
| Depreciation | 147 | 28.40 | 23.80 | 25.00 | 23.62 | 25.16 | 26.39 |
| Interest | 98.10 | 12.00 | 24.00 | 16.10 | 25.51 | 83.80 | 140 |
| Profit before tax | 230 | 359 | 260 | 291 | 306 | 112 | 121 |
| Tax | 33.30 | 11.90 | (6.80) | (19.50) | (2.85) | (6.52) | (20.45) |
| Net profit | 229 | 331 | 279 | 319 | 309 | 251 | 181 |
| Net profit margin | +5.8% | +12.2% | +12.0% | +14.2% | +15.4% | +13.4% | +10.2% |
| EPS (βΉ) | 6.20 | 54.54 | 41.97 | 48.81 | 48.54 | 18.66 | 24.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 63.60 | 63.60 | 63.60 | 63.60 | 63.63 | 63.63 | 57.66 |
| Reserves & surplus | 5,762 | 5,608 | 5,294 | 5,059 | 4,780 | 4,504 | 3,403 |
| Shareholders' funds (net worth) | 5,826 | 5,672 | 5,358 | 5,123 | 4,844 | 4,568 | 3,461 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 6.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,516 |
| Unsecured loans | 3,196 | 188 | 329 | 297 | 387 | 550 | 2.89 |
| Total debt | 3,203 | 188 | 329 | 297 | 387 | 550 | 1,519 |
| Total liabilities | 9,103 | 5,883 | 5,704 | 5,434 | 5,246 | 5,133 | 4,994 |
| Assets | |||||||
| Gross block | 9,004 | 5,389 | 4,934 | 4,961 | 4,919 | 4,858 | 4,844 |
| Net block | 8,596 | 5,125 | 4,708 | 4,732 | 4,710 | 4,667 | 4,674 |
| Capital work in progress | 23.10 | 15.10 | 9.70 | 13.00 | 11.92 | 3.74 | 3.53 |
| Investments | 5.10 | 36.40 | 77.60 | 70.00 | 27.02 | 0.00 | 110 |
| Inventories | 764 | 518 | 468 | 458 | 362 | 365 | 292 |
| Sundry debtors | 384 | 367 | 283 | 208 | 142 | 94.28 | 118 |
| Cash & bank balances | 111 | 73.90 | 240 | 38.10 | 170 | 253 | 82.42 |
| Loans & advances | 104 | 110 | 147 | 134 | 113 | 135 | 172 |
| Total current assets | 1,362 | 1,068 | 1,137 | 838 | 787 | 847 | 665 |
| Total current liabilities | 573 | 559 | 444 | 399 | 447 | 534 | 596 |
| Net working capital | 790 | 510 | 694 | 439 | 340 | 313 | 69.41 |
| Total assets | 9,103 | 5,883 | 5,704 | 5,434 | 5,246 | 5,133 | 4,994 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 66.70 | 80.00 | 37.00 | 170 | 253 | 193 | 210 |
| Net cash from operating activities | 226 | 380 | 246 | 91.70 | 237 | 287 | 259 |
| Net cash from investing activities | (2,881) | (207) | (178) | (84.90) | (58.93) | (10.41) | (17.12) |
| Net cash from financing activities | 2,698 | (186) | (25.70) | (138) | (234) | (216) | (260) |
| Net change in cash | 43.90 | (13.30) | 43.00 | (132) | (55.90) | 59.89 | (17.56) |
| Closing cash | 111 | 73.90 | 240 | 38.10 | 170 | 253 | 82.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +46.2% | +16.4% | +3.2% | +12.2% | +7.6% | +5.7% | - |
| EBITDA growth | +23.5% | +30.7% | -11.2% | -5.1% | +62.4% | -23.3% | - |
| PBT growth | -35.8% | +38.0% | -10.6% | -4.9% | +172.7% | -7.5% | -28.9% |
| Net income growth | -30.8% | +18.5% | -12.6% | +3.3% | +23.1% | +38.8% | - |
| Revenue CAGR (3Y) | +20.7% | +10.5% | +7.6% | +8.5% | +33.6% | +53.9% | +60.1% |
| EBITDA CAGR (3Y) | +12.8% | +3.3% | +11.0% | +5.7% | +25.5% | +19.2% | +40.9% |
| Profitability & leverage | |||||||
| Net income margin | +5.0% | +12.8% | +11.5% | +13.8% | +15.4% | +6.4% | +8.0% |
| Return on capital employed | +4.9% | +6.4% | +5.1% | +5.8% | +6.4% | +6.5% | +6.0% |
| Return on net worth | +4.0% | +6.3% | +5.1% | +6.2% | +6.6% | +6.3% | +5.3% |
| Debt / equity | 0.29 | 0.05 | 0.06 | 0.07 | 0.10 | 0.26 | 0.45 |
| Long-term debt / equity | 0.27 | 0.00 | 0.00 | 0.01 | 0.04 | 0.23 | 0.44 |
| Interest cover | 30.45 | 3.42 | 9.00 | 5.33 | 7.94 | 44.80 | 55.86 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.55 | 0.52 | 0.47 | 0.46 | 0.41 | 0.38 | 0.37 |
| Inventory turnover | 6.18 | 5.50 | 5.03 | 5.51 | 5.53 | 5.68 | 6.73 |
| Debtors turnover | 10.55 | 8.33 | 9.48 | 12.88 | 16.98 | 17.57 | 16.49 |
| EPS (βΉ) | 6.20 | 54.54 | 41.97 | 48.81 | 48.54 | 18.66 | 24.58 |
| Dividend per share (βΉ) | 1.20 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Book value per share (βΉ) | 183.21 | 891.76 | 842.37 | 805.44 | 761.28 | 717.87 | 600.18 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 153 | 133 | 153 | 156 | 141 | 128 | 99.70 | 63.30 |
| Revenue growth (YoY) | +8.6% | +3.7% | +53.1% | +146.5% | +122.2% | - | - | - |
| Other income | 4.90 | 4.80 | 4.40 | 2.00 | 0.70 | 0.50 | 3.20 | 4.10 |
| Total expenses | 141 | 113 | 133 | 138 | 125 | 114 | 84.80 | 55.80 |
| EBITDA | 11.80 | 19.80 | 19.20 | 18.40 | 15.50 | 14.20 | 14.90 | 7.50 |
| EBITDA margin | +8.7% | +17.8% | +13.6% | +12.7% | +11.9% | +12.2% | +16.8% | +14.1% |
| Depreciation | 6.30 | 6.30 | 6.30 | 6.40 | 6.00 | 7.40 | 1.00 | 0.90 |
| Interest | 3.00 | 3.10 | 3.10 | 2.50 | 2.30 | 2.10 | 1.40 | 0.20 |
| Profit before tax | 7.40 | 15.20 | 14.20 | 11.50 | 7.90 | 5.20 | 15.70 | 10.50 |
| Tax | 1.90 | 1.90 | 2.10 | 3.90 | 3.30 | 1.50 | 3.90 | 2.50 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 582 | 354 | 245 | 251 | 216 | 114 | 153 |
| Revenue growth | +64.3% | +44.7% | -2.6% | +16.2% | +90.0% | -25.8% | - |
| Other income | 11.90 | 12.60 | 18.00 | 13.50 | 15.40 | 66.80 | 109 |
| Total expenses | 509 | 312 | 212 | 213 | 222 | 291 | 175 |
| Employee cost | 56.80 | 48.70 | 29.90 | 29.10 | 31.06 | 30.64 | 31.68 |
| EBITDA | 72.90 | 41.90 | 33.00 | 38.30 | (5.32) | (177) | (21.18) |
| EBITDA margin | +12.5% | +11.8% | +13.5% | +15.3% | -2.5% | -155.3% | -13.8% |
| Depreciation | 25.00 | 10.20 | 3.60 | 3.50 | 2.84 | 3.49 | 2.95 |
| Interest | 11.00 | 4.50 | 2.60 | 1.10 | 2.02 | 74.66 | 140 |
| Profit before tax | 48.80 | 39.80 | 44.80 | 47.20 | 5.22 | (188) | (54.94) |
| Tax | 11.20 | 10.10 | 11.10 | (19.20) | (7.48) | (5.99) | (14.21) |
| Net profit | 45.92 | 28.20 | 33.10 | 66.20 | 12.70 | (55.81) | (40.44) |
| Net profit margin | +7.9% | +8.0% | +13.5% | +26.4% | +5.9% | -49.0% | -26.4% |
| EPS (βΉ) | 1.18 | 4.67 | 5.30 | 10.44 | 2.00 | (28.62) | (7.06) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 63.60 | 63.60 | 63.60 | 63.60 | 63.63 | 63.63 | 57.66 |
| Reserves & surplus | 3,969 | 3,970 | 3,972 | 3,971 | 3,937 | 3,956 | 3,157 |
| Shareholders' funds (net worth) | 4,033 | 4,034 | 4,036 | 4,034 | 4,000 | 4,019 | 3,215 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,516 |
| Unsecured loans | 181 | 130 | 50.70 | 0.30 | 46.48 | 50.40 | 0.14 |
| Total debt | 181 | 130 | 50.70 | 0.30 | 46.48 | 50.40 | 1,516 |
| Total liabilities | 4,221 | 4,170 | 4,091 | 4,038 | 4,049 | 4,073 | 4,734 |
| Assets | |||||||
| Gross block | 496 | 484 | 96.50 | 94.30 | 85.57 | 81.92 | 77.56 |
| Net block | 420 | 432 | 54.10 | 54.50 | 45.00 | 44.05 | 42.72 |
| Capital work in progress | 4.90 | 8.00 | 4.00 | 0.50 | 1.77 | 0.87 | 1.47 |
| Investments | 3,671 | 3,678 | 3,676 | 3,698 | 3,683 | 3,671 | 3,528 |
| Inventories | 28.30 | 26.00 | 10.10 | 9.00 | 9.05 | 15.18 | 12.34 |
| Sundry debtors | 27.50 | 23.90 | 7.80 | 2.90 | 11.02 | 1.71 | 0.55 |
| Cash & bank balances | 7.50 | 11.00 | 9.60 | 15.40 | 57.35 | 84.00 | 29.80 |
| Loans & advances | 47.50 | 42.10 | 99.50 | 116 | 32.34 | 31.35 | 44.95 |
| Total current assets | 111 | 103 | 127 | 143 | 110 | 132 | 87.64 |
| Total current liabilities | 52.60 | 80.80 | 24.90 | 28.30 | 41.26 | 43.64 | 68.59 |
| Net working capital | 58.20 | 22.20 | 102 | 115 | 68.50 | 88.60 | 19.05 |
| Total assets | 4,221 | 4,170 | 4,091 | 4,038 | 4,049 | 4,073 | 4,734 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 4.20 | 9.20 | 14.90 | 57.30 | 84.00 | 29.80 | 42.98 |
| Net cash from operating activities | 35.20 | 40.00 | 26.00 | 36.70 | (16.27) | (51.73) | (19.67) |
| Net cash from investing activities | (32.00) | (88.40) | (47.10) | 0.70 | 39.33 | 816 | 267 |
| Net cash from financing activities | (0.30) | 43.40 | 15.40 | (79.30) | (37.69) | (710) | (260) |
| Net change in cash | 2.90 | (5.00) | (5.70) | (41.90) | (14.63) | 54.20 | (13.18) |
| Closing cash | 7.50 | 11.00 | 9.60 | 15.40 | 57.35 | 84.00 | 29.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +64.3% | +44.7% | -2.6% | +16.2% | +90.0% | -25.8% | - |
| EBITDA growth | +74.0% | +27.0% | -13.8% | +819.9% | +97.0% | -734.7% | - |
| PBT growth | +22.6% | -11.2% | -5.1% | +804.2% | +9998.0% | -242.4% | - |
| Net income growth | +62.8% | -14.8% | -50.0% | +421.3% | +122.8% | -38.0% | - |
| Revenue CAGR (3Y) | +32.3% | +17.9% | +29.1% | +17.9% | -5.3% | -24.5% | -12.0% |
| EBITDA CAGR (3Y) | +23.9% | - | - | - | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +6.5% | +8.4% | +13.8% | +26.4% | +5.9% | -160.0% | -26.6% |
| Return on capital employed | +1.7% | +1.1% | +1.2% | +1.2% | +0.2% | +0.3% | +1.8% |
| Return on net worth | +1.1% | +0.7% | +0.8% | +1.7% | +0.3% | -1.5% | -1.3% |
| Debt / equity | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0.22 | 0.47 |
| Long-term debt / equity | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.21 | 0.46 |
| Interest cover | 22.96 | 14.20 | 8.84 | 3.16 | -24.75 | -41.42 | -581.39 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.19 | 1.22 | 2.57 | 2.79 | 2.58 | 1.43 | 2.09 |
| Inventory turnover | 21.44 | 19.63 | 25.63 | 27.83 | 17.85 | 8.27 | 17.03 |
| Debtors turnover | 22.65 | 22.35 | 45.76 | 36.09 | 33.97 | 100.73 | 44.86 |
| EPS (βΉ) | 1.18 | 4.67 | 5.30 | 10.44 | 2.00 | (28.62) | (7.06) |
| Dividend per share (βΉ) | 1.20 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Book value per share (βΉ) | 126.81 | 634.20 | 634.58 | 634.32 | 628.66 | 631.67 | 557.53 |
Competitors of Everyuth
Everyuth has 3 listed competitors in our database, 3 of them funded. They include Mamaearth, WOW Skin Science and Juicy Chemistry.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mamaearth.in | 2016 | Gurugram, India | $89.36M | 1,900 | Online brand offering multi-category natural skin care and makeup products | |
| buywow.in | 2014 | Bengaluru, India | $98M | 100 | Organic beauty products are offered by an internet-first brand. | |
| juicychemistry.com | 2014 | Coimbatore, India | $7.56M | 52 | Natural skin and hair care products are sold online. |
Detailed competitors of Everyuth
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Everyuth
The website of Everyuth (everyuth.com) receives about 9.7K visits a month.
- Monthly visits9.7K
▼ 24.2% vs previous month
Websites whose visitors overlap most with Everyuth. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ozoneayurvedics.com | ozoneayurvedics.com | 100% | #1,463,576 | β | |
lauraloukola.net | lauraloukola.net | 88% | #1,561,668 | β | |
thebarebar.in | thebarebar.in | 84% | #439,561 | β | |
| glamveda.com | 84% | 21.7K | #1,510,621 | View details | |
| goodvibesonly.in | 81% | 18.5K | #1,127,642 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Everyuth
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Everyuth (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online platform offering a wide range of baby, kids, and maternity products | 2010 | Pune, Maharashtra, India | USD 513.39 M | USD 911.07 M | 3,752 | |
Online brand offering mens grooming products | 2015 | Gurugram, Haryana, India | USD 52.66 M | |||
Retailer of perfumes, cosmetics, skincare, and related gift set items | 2012 | Gurugram, Haryana, India | USD 60.63 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Everyuth
Complete news archive for Everyuth
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Everyuth
Everyuth was founded in 2013.
Everyuth is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Everyuth has 129 employees.
The primary company behind Everyuth, Zydus Wellness Limited, reported revenue of βΉ3,967 Cr for FY 2026, up 46% year on year.
Everyuth Naturals is an online platform specializing in skincare products, including scrubs, peel-off masks, face washes, and lotions designed for benefits like exfoliation and hydration. It operates through an e-commerce site where users can browse categories and select products based on skin types. The company provides resources such as blogs on skincare routines and product guides, targeting consumers seeking effective, everyday skin solutions. Activities include product sales, educational content, and trend updates, though specific locations are not detailed.
Everyuth's top competitors include Mamaearth, WOW Skin Science and Juicy Chemistry.
Everyuth offers Scrub, Peel Off Mask, Face Wash, Tan Removal, and 2 more products and services.
Yes, Everyuth is publicly traded on NSE under the ticker symbol ZYDUSWELL.
Everyuth operates through Zydus Wellness Limited.
The legal entities of Everyuth currently have 10 directors, including Ganesh Narayan Nayak, Tarun Arora, Kulin Sanjay Lalbhai and others.
